Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinical Case Reports Année : 2020

Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia.

Résumé

We report a case of refractory life-threatening warm autoimmune hemolytic anemia (wAIHA) associated with chronic myelomono-cytic leukemia (CMML) for which all conventional treatments had failed. The use of eculizumab allowed controlling hemolysis and resulted in transfusion independence. These data support the use of eculizumab in refractory wAIHA.

Domaines

Hématologie
Fichier principal
Vignette du fichier
443751.pdf (138.37 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02904268 , version 1 (21-07-2020)

Identifiants

Citer

Anne-Cécile Gauchy, Maxime Hentzien, Alain Wynckel, Victoire de Marcellus, Cyrielle Rodier, et al.. Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia.. Clinical Case Reports, 2020, ⟨10.22541/au.158739918.81604679⟩. ⟨hal-02904268⟩

Collections

URCA VIEFRA
93 Consultations
126 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More